Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Treasury Shares (2022 - 2025)

Maxcyte (MXCT) has disclosed Treasury Shares for 4 consecutive years, with $1.8 million as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 5.97% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, up 5.97% year-over-year, with the annual reading at $1.8 million for FY2025, 5.97% up from the prior year.
  • Treasury Shares for Q4 2025 was $1.8 million at Maxcyte, up from $1.7 million in the prior quarter.
  • The five-year high for Treasury Shares was $1.8 million in Q4 2025, with the low at $643600.0 in Q4 2022.
  • Average Treasury Shares over 4 years is $1.4 million, with a median of $1.5 million recorded in 2023.
  • The sharpest move saw Treasury Shares skyrocketed 101.4% in 2023, then rose 5.97% in 2025.
  • Over 4 years, Treasury Shares stood at $643600.0 in 2022, then soared by 101.4% to $1.3 million in 2023, then skyrocketed by 31.47% to $1.7 million in 2024, then increased by 5.97% to $1.8 million in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $1.8 million, $1.7 million, and $1.3 million for Q4 2025, Q4 2024, and Q4 2023 respectively.